DR AGARWALS HEALTH CARE L
Latest filings
Next results: Thu, 5 Nov · Financial Results- Board meeting and earnings call set for November 5, 2026 · Results
- Board meeting set for November 5, 2026 results · Results
- 18,200 shares allotted to employees under stock option scheme · Capital Market Events
Snapshot
What the business is, and whether it's a good one at a fair price.
Operates a chain of eye-care hospitals and primary clinics across India, with FY26 revenue from operations of INR 2,080 crores. Surgical services contributed 67% of group revenue, with the balance from primary clinics and consultations. In FY26 the network performed 3,23,000+ surgeries (up 14.5% YoY), including 62,800 cataract procedures, of which 5,900+ were robotic Femto Cataract surgeries. Patient payor mix stood at 62.4% cash, 28.5% insurance/TPA and 9% government schemes. Employee costs of 19.4% of revenue are the largest named operating cost, alongside other operating expenses of 43.9% and depreciation at 13.3% of revenue. The business is in an expansion phase, having commissioned 19 greenfield facilities in Q4 FY26 and guiding to 60 more in FY27 (40 surgical centres and 20 clinics) with planned capex of INR 380-400 crores.
Scorecard
Measured from the filed financials, judged against its Hospital peers · as of FY26 — not investment advice
Strengths
Concerns
Nothing flagged in the filed numbers.Charts
How has the market priced it — with filings on the timeline?
AGARWALEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from DR AGARWALS HEALTH CARE L's filed financials and exchange disclosures
What does DR AGARWALS HEALTH CARE L do?
DR AGARWALS HEALTH CARE L is a Healthcare Services company listed on NSE and BSE, trading under the symbol AGARWALEYE.
Is DR AGARWALS HEALTH CARE L profitable?
Yes. Over the trailing twelve months DR AGARWALS HEALTH CARE L reported a net profit of ₹185 Cr on revenue of ₹2,207 Cr.
Does DR AGARWALS HEALTH CARE L pay a dividend?
Yes. The dividend yield is 0.01% at the current price. It paid out 1% of its profit as dividend in FY26.
Is DR AGARWALS HEALTH CARE L debt-free?
No. It reported borrowings of ₹157 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹67 Cr after cash. Debt stands at 0.07× equity. That is lower than 74% of its 24 Hospital peers.
Is DR AGARWALS HEALTH CARE L expensive compared with its peers?
On trailing P/E, DR AGARWALS HEALTH CARE L ranks 26 of 30 in Hospital — cheaper than 14% of them, against an industry median of 42.2×. This is a position, not a valuation judgement.
How much does the DR AGARWALS HEALTH CARE L share price move in a day?
On a typical session DR AGARWALS HEALTH CARE L moves 0.96% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.
When are DR AGARWALS HEALTH CARE L's next results?
Financial Results on Thu, 5 Nov. MarketPing alerts you on WhatsApp the moment the filing lands.
Where can I track DR AGARWALS HEALTH CARE L's announcements?
Every NSE and BSE filing by DR AGARWALS HEALTH CARE L appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.